WebMD: How are depression and substance abuse related?
UC faculty member Keith King speaks to addiction and mental health issues
Substance abuse and depression very often go hand in hand, explains a WebMD article where Keith King, professor and head of UC’s School of Human Services, is cited as an expert.
King serves as the director of UC’s Center for Presentation Science and has spent the past two decades researching mental health issues and preventions.
“Do your research” King says of taking stock of symptoms in oneself and others, relaying that “maybe a third – and that’s being generous” of people who have depression seek help. And with substance abuse, he says, “denial is also a huge problem.”
Read the entire article online.
Featured image at top: Dan Meyers/Unsplash
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.